DentalCare Logo

Postexposure Evaluation and Follow-up

Course Number: 472

PDF

References / Additional Resources

  1. U.S. Department of Labor, Occupational Safety and Health Administration. 29 CFR Part 1910.1030. Occupational exposure to bloodborne pathogens. Accessed May , 2023.

  2. Centers for Disease Control and Prevention. Guidelines for Infection Control in Dental Health-Care Settings. 2003. MMWR 2003;52(No. RR-17):1-76.

  3. Siegel JD, Rhinehart E, Jackson M, et al. 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. Accessed May 15, 2023.

  4. Centers for Disease Control and Prevention. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR 2001:50(No. RR-11):1-67

  5. Centers for Disease Control and Prevention. CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. MMWR 2013:62(No. RR-10):1-19

  6. Henderson DK, Dembry L, Fishman NO, et al. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus. Infect Control Hosp Epidemiol. 2010;31(3):203-232. doi:10.1086/650298.

  7. Michelin A, Henderson DK. Infection control guidelines for prevention of health care-associated transmission of hepatitis B and C viruses. Clin Liver Dis. 2010;14(1):119-x. doi:10.1016/j.cld.2009.11.005.

  8. Centers for Disease Control and Prevention. Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus — CDC Guidance, United States, 2020. MMWR 2020:69(No. RR-6):1-8.

  9. Kuhar DT, Henderson DK, Struble KA, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis [published correction appears in Infect Control Hosp Epidemiol. 2013 Nov;34(11):1238. Dosage error in article text]. Infect Control Hosp Epidemiol. 2013;34(9):875-892. doi:10.1086/672271.

  10. Shefer A, Atkinson W, Friedman C, et al. Immunization of health-care personnel:. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011:60(No. RR-7):1-45

  11. Centers for Disease Control and Prevention. Measles (Rubeola). Accessed May 15, 2023.

  12. Workowski KA, Bachmann LH, Cahn PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep 2021:70(No. RR-4):1-187.

  13. CDC Health Alert Network Advisory CDCHAN-00482. Interim Guidance for Clinicians to Prioritize Antiviral Treatment of Influenza in the Setting of Reduced Availability of Oseltamivir. Dec 14, 2022. Accessed May 15, 2023.

  14. Centers for Disease Control and Prevention. Overview of Covid-19 Vaccines. Updated May 23, 2032. Accessed August 4, 2023.

  15. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005. MMWR Recomm Rep 2005:54(No. RR-17):1-121

  16. Sosa LF, Nijie GJ, Lobato MN, et al. Tuberculosis Screening, Testing, and Treatment of U.S. Health Care Personnel: Recommendations from the National Tuberculosis Controllers Association and CDC, 2019. MMWR 2019;68(No. 19):1-5

  17. Centers for Disease Control and Prevention. Diphtheria, Tetanus, and Pertussis Vaccine Recommendations. Accessed May 15, 2023.

  18. Centers for Disease Control and Prevention. Tetanus. For Clinicians. Accessed May 15, 2023.

  19. Centers for Disease Control and Prevention. Diphtheria. Accessed May 15, 2023.

  20. Centers for Disease Control and Prevention. Meningococcal Vaccine Recommendations. Accessed May 15, 2023.

  21. Centers for Disease Control and Prevention. Meningococcal Disease. Accessed May 15, 2023.

  22. Centers for Disease Control and Prevention. Pneumococcal Disease. Accessed May 15, 2023.

  23. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus (MRSA). Accessed May 15, 2023.

  24. Centers for Disease Control and Prevention. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep 2020:69(No. RR-5):1-42.

  25. Centers for Disease Control and Prevention. Summary of Infection Prevention Practices in Dental Settings: Basic Expectations for Safe Care. Accessed August 8, 2023.

Additional Resources


No Additional Resources Available

0/20Next